Skip to main content
. Author manuscript; available in PMC: 2007 Oct 24.
Published in final edited form as: J Biol Chem. 2001 Sep 10;276(48):44527–44533. doi: 10.1074/jbc.M106771200

TABLE I. Ligation of CD40 by cross-linking antibodies against either CD40 or human recombinant CD40L stimulates the production of NO in IFN-γ-treated mouse primary microglia and macrophages.

Mouse primary microglia and peritoneal macrophages were cultured for 24 h with IFN-γ (25 units/ml) and different concentrations of either cross-linking antibodies against CD40 or human recombinant CD40L under serum-free conditions and nitrite concentration in the supernatants was measured as described under “Materials and Methods.” Data are mean ± S.D. of three different experiments. ND, not determined.

Treatments Nitrite

Microglia Macrophages
μg/mg protein/24 h
Control 11.7 ± 1.5 12.5 ± 1.6
IFN-γ alone 146.8 ± 16 176.5 ± 21.5
Anti-CD40 (2 μg/ml) alone 12.9 ± 1.1 14.6 ± 1.2
IFN-γ + anti-CD40 (1 μg/ml) 321 ± 36 348 ± 29
IFN-γ + anti-CD40 (2 μg/ml) 412 ± 31 482 ± 55
CD40L (2 μg/ml) alone ND 15.1 ± 1.9
IFN-γ + CD40L (1 μg/ml) ND 312 ± 23
IFN-γ + CD40L (2 μg/ml) ND 407 ± 34
HHS Vulnerability Disclosure